Vinblastine First-Line Option for Pediatric Low-Grade Glioma

Vinblastine monotherapy produced outcomes similar to current therapies in children with treatment-naive pediatric low-grade glioma, and had favorable toxicity and quality-of-life profiles.

Source: CancerNetwork - September 3, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Brain Tumors News Source Type: news